Dilated cardiomyopathy and heart failure in children

Heart Fail Clin. 2010 Oct;6(4):415-32, vii. doi: 10.1016/j.hfc.2010.05.003.

Abstract

This article describes the causes and outcomes of dilated cardiomyopathy in children. Genetic, infectious, metabolic, and acquired causes of dilated cardiomyopathy are discussed. The predictors for better and worse outcomes are reviewed. Guidelines for the use of medical and surgical therapies to treat heart failure in children are summarized.

Publication types

  • Review

MeSH terms

  • Cardiomyopathy, Dilated / diagnosis
  • Cardiomyopathy, Dilated / epidemiology
  • Cardiomyopathy, Dilated / etiology*
  • Cardiomyopathy, Dilated / therapy*
  • Cardiotonic Agents / therapeutic use
  • Child
  • Defibrillators, Implantable
  • Genetic Predisposition to Disease
  • Heart Failure / classification
  • Heart Failure / etiology
  • Heart Failure / mortality
  • Heart Failure / therapy*
  • Heart Transplantation
  • Heart-Assist Devices
  • Humans
  • Metabolism, Inborn Errors / complications
  • Mitral Valve / surgery
  • Mitral Valve Insufficiency / surgery
  • Myocarditis / complications
  • Myocarditis / diagnosis
  • Pacemaker, Artificial
  • Phenotype
  • Prognosis

Substances

  • Cardiotonic Agents